Peter H J Slootbeek

9PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2026
Shallow Whole-Genome Sequencing to Assess Genomic Instability and Predict Treatment Response in Metastatic Castration-Resistant Prostate Cancer.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Jan 23, 2026
Assessing the Detection Power of Genome-Wide Copy Number Variation Profiles in Prostate Cancer Using Simulated Shallow Whole-Genome Sequencing Data.

Samhita Pamidimarri Naga, Peter H J Slootbeek, Sofie H Tolmeijer

|Nov 01, 2025
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study.

Iris S H Kloots, Peter H J Slootbeek, Sofie H Tolmeijer

|Oct 26, 2023
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?

Peter H J Slootbeek, Sofie H Tolmeijer, Niven Mehra

|Jun 22, 2023
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer.

Peter H J Slootbeek, Iris S H Kloots, Inge M van Oort

Pageof 2

Frequent Collaborators

9 joint publications

Niven Mehra

5 joint publications

Jack A Schalken

5 joint publications

Marjolijn J L Ligtenberg

3 joint publications

Iris S H Kloots